The global life sciences industry is confronted with a host of challenges, including the healthcare crisis in many countries (especially the US), a declining patents regime, growing competition from generic producers, greater regulatory scrutiny, pricing pressures, changing demographics and the emergence of new untapped markets.
Estimates are that the global pharmaceuticals, biotechnology and life sciences industry generated revenues of over $1.1 trillion in 2011, with pharmaceuticals accounting for nearly $800 billion and biotechnology about $300 billion. A rapidly ageing population in the developed world and healthcare reforms that are bringing in millions of uninsured citizens in the US into the insurance net are expected to boost demand for pharmaceuticals and life science products.
We have a select clientele from across the pharmaceuticals, biologics, immunology, medical device, biopharma, healthcare equipment, hospital software, and other life sciences companies. Our solutions are wide-ranging, from serialization to aid in packaging, anti-diversion measures at the packaging lines and distribution system, and IT upgrades to meet the changing regulatory environment, to turnkey IT projects and staffing solutions.